Menu

Patient Criteria for Treatment in CLL

December 7, 2022 | Video Library | CAPE CLL
Featuring:
Chelsea Passwater, DNP, RN, AGCNS-BC, OCN
Chelsea Passwater, DNP, RN, AGCNS-BC, OCN
Clinical Associate Professor
East Carolina University
Greenville, NC

Our CLL clinical advisor examines indications for treatment in CLL for both symptomatic patients and asymptomatic patients as well as the navigator’s touchpoints during this phase.

Related Articles
Overview of Chronic Lymphocytic Leukemia (CLL)
Chelsea Passwater, DNP, RN, AGCNS-BC, OCN
December 7, 2022 | Video Library | CAPE CLL
Watch as our CLL clinical advisor dives deeper into defining CLL, the clinical staging systems developed for this disease, and the role navigators play in the patient’s treatment journey.
CLL: Watch and Wait Period
Nikki Barkett, BSN, RN, OCN
December 7, 2022 | Video Library | CAPE CLL
Listen in as our CLL clinical advisor examines the “Watch and Wait” period in CLL and impact navigation can have during this period.
The Role of Genetics in CLL
Chelsea Passwater, DNP, RN, AGCNS-BC, OCN
December 7, 2022 | Video Library | CAPE CLL
A look at understanding the complexities of mutations and cytogenetics in CLL, the role genetics plays in prognosis, and how navigators can educate their patients and caregivers.

Thank You to Our Corporate Sponsors and Alliance Partners!

  • Major Corporate Sponsor

    Major Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Industry Relations Council Member

    Industry Relations Council Member

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Patron Corporate Sponsor

    Patron Corporate Sponsor

  • Industry Relations Council Member

    Industry Relations
    Council Member

  • Industry Relations Council Member

    Industry Relations Council Member

  • National Alliance Partner

    National Alliance Partner

  • National Alliance Partner

    National Alliance Partner